Kura Oncology (KURA) Stock: Buy, Sell, or Hold?
KURA - Kura Oncology, Inc.
$10.65
0.00 (0.00%)
▲
5d:
-1.02%
30d:
-18.76%
90d:
-3.53%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 03, 2026
30d
Get Alerted When KURA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: KURA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: KURA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: KURA is currently trading at $10.65, which is considered oversold relative to its 30-day fair value range of $10.94 to $12.81.
Technical Outlook: Technically, KURA is in a uptrend. The price is currently testing key support at $10.36. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: KURA scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $31.85 (+199.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, KURA is in a uptrend. The price is currently testing key support at $10.36. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: KURA scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $31.85 (+199.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$10.94 -
$12.81
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 199.0% below Wall St target ($31.85)
- CAUTION: Bottoming setup, but lagging the sector by 33% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$10.94 -
$12.81
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$10.36
Resistance Level
$12.00
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.53
Wall Street Target
$31.85
(+199.0%)
Revenue Growth (YoY)
36.5%
Share & Embed Analysis
Last updated: October 03, 2026 6:28 AM ET
Data refreshes hourly during market hours. Next update: 7:28 AM
Data refreshes hourly during market hours. Next update: 7:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KURA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$92 | 46 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 65 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 76 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 42 HOLD |
